Increased serum interleukin-9 levels in rheumatoid arthritis and systemic lupus erythematosus: Pathogenic role or just an epiphenomenon?

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Dantas, Andréa Tavares ^a   Marques, Claudia Diniz Lopes ^a   Da Rocha Junior, Laurindo Ferreira ^a   Cavalcanti, Mariana Brayner ^a   Gonçalves, Sayonara Maria Calado ^a   Cardoso, Pablo Ramon Gualberto ^a   De Ataide Mariz, Henrique ^a   De Melo Rego, Moacyr Jesus Barreto ^a   Duarte, Angela Luzia Branco Pinto ^a   Da Rocha Pitta, Ivan ^a   Da Rocha Pitta, Maira Galdino ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; DNA ANTIBODY; INTERLEUKIN 9; RHEUMATOID FACTOR; BIOLOGICAL MARKER; IL9 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DAS28; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EROSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOGRAPHY; RHEUMATOID ARTHRITIS; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; METABOLISM; MIDDLE AGED; UPREGULATION; YOUNG ADULT;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BIOMARKERS; FEMALE; HUMANS; INTERLEUKIN-9; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; UP-REGULATION; YOUNG ADULT;

EID: 84930958971     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/519638     Document Type: Article

References (43)

1. K. Siegmund, M. Feuerer, C. Siewert et al., "Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo," Blood, vol. 106, no. 9, pp. 3097-3104, 2005.
2. Y. Rochman, R. Spolski, and W. J. Leonard, "New insights into the regulation of T cells by gamma(c) family cytokines," Nature Reviews Immunology, vol. 9, no. 7, pp. 480-490, 2009.
3. M. Stassen, E. Schmitt, and T. Bopp, "From interleukin-9 to T helper 9 cells," Annals of the New York Academy of Sciences, vol. 1247, no. 1, pp. 56-68, 2012.
4. G. Beriou, E.M. Bradshaw, E. Lozano et al., "TGF-β induces IL-9 production from human Th17 cells," The Journal of Immunology, vol. 185, no. 1, pp. 46-54, 2010.
5. E. C. Nowak, C. T. Weaver,H. Turner et al., "IL-9 as a mediator of Th17-driven inflammatory disease," The Journal of Experimental Medicine, vol. 206, no. 8, pp. 1653-1660, 2009.
6. W. Elyaman, E.M. Bradshaw, C.Uyttenhove et al., "IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 31, pp. 12885-12890, 2009.
7. A. Jäger, V. Dardalhon, R. A. Sobel, E. Bettelli, and V. K. Kuchroo, "Th1, Th17, andTh9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes," The Journal of Immunology, vol. 183, no. 11, pp. 7169-7177, 2009.
8. A. Visekruna, J. Ritter, T. Scholz et al., "Tc9 cells, a new subset of CD8+ T cells, support Th2-mediated airway inflammation," European Journal of Immunology, vol. 43, no. 3, pp. 606-618, 2013.
9. N. Sismanopoulos, D. A. Delivanis, K. D. Alysandratos et al., "IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis," PLoS ONE, vol. 7, no. 3,Article ID e33271, 2012.
10. U. Grohmann, J. van Snick, F. Campanile et al., "IL-9 protects mice from gram-negative bacterial shock: suppression of TNFalpha, IL-12, and IFN-gamma, and induction of IL-10," The Journal of Immunology, vol. 164, no. 8, pp. 4197-4203, 2000.
11. C. Pilette, Y. Ouadrhiri, J. van Snick et al., "IL-9 inhibits oxidative burst and TNF-α release in lipopolysaccharide-stimulated humanmonocytes through TGF-β,"TheJournal of Immunology, vol. 168, no. 8, pp. 4103-4111, 2002.
12. D.-Y. Chen, Y.-M. Chen, M.-C. Wen, T.-Y. Hsieh, W.-T. Hung, and J.-L. Lan, "The potential role of Th17 cells andTh17-related cytokines in the pathogenesis of lupus nephritis," Lupus, vol. 21, no. 13, pp. 1385-1396, 2012.
13. C. K. Wong, L. C. W. Lit, L. S. Tam, E. K. M. Li, P. T. Y. Wong, and C. W. K. Lam, "Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity," Clinical Immunology, vol. 127, no. 3, pp. 385-393, 2008.
14. J. Kim, S. Kang, G. Kwon, and S. Koo, "Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis," Annals of Laboratory Medicine, vol. 33, no. 1, pp. 52-59, 2013.
15. J.M. Hughes-Austin, K. D. Deane, L. A. Derber et al., "Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: studies of the Aetiology of Rheumatoid Arthritis (SERA)," Annals of the Rheumatic Diseases, vol. 72, no. 6, pp. 901-907, 2013.
16. H. Ouyang, Y. Shi, Z. Liu et al., "Increased Interleukin-9 and CD4+IL-9+ T cells in patients with Systemic lupus erythematosus," Molecular Medicine Reports, vol. 7, no. 3, pp. 1031-1037, 2013.
17. M. C. Hochberg, "Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus," Arthritis and Rheumatism, vol. 40, no. 9, p. 1725, 1997.
18. F. C. Arnett, S. M. Edworthy,D. A. Bloch et al., "The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis," Arthritis and Rheumatism, vol. 31, no. 3, pp. 315-324, 1988.
19. R. Goswami and M. H. Kaplan, "A brief history of IL-9," Journal of Immunology, vol. 186, no. 6, pp. 3283-3288, 2011.
20. U. A. Temann, P. Ray, and R. A. Flavell, "Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology," TJournal of Clinical Investigation, vol. 109, no. 1, pp. 29-39, 2002.
21. U.-A. Temann, G. P. Geba, J. A. Rankin, and R. A. Flavell, "Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness," The Journal of Experimental Medicine, vol. 188, no. 7, pp. 1307-1320, 1998.
22. E. E. Forbes, K. Groschwitz, J. P. Abonia et al., "IL-9-and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity,"The Journal of Experimental Medicine, vol. 205, no. 4, pp. 897-913, 2008.
23. H. Faulkner, J.-C. Renauld, J. Van Snick, and R. K. Grencis, "Interleukin-9 enhances resistance to the intestinal nematode Trichuds muris," Infection and Immunity, vol. 66, no. 8, pp. 3832-3840, 1998.
24. C. Tan, M. K. Aziz, J.D. Lovaas et al., "Antigen-specificTh9cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site," Journal of Immunology, vol. 185, no. 11, pp. 6795-6801, 2010.
25. J. Burkhardt, E. Petit-Teixeira, V. H. Teixeira et al., "Association of the X-chromosomal genes TIMP1 and IL9R with rheumatoid arthritis,"The Journal of Rheumatology, vol. 36, no. 10, pp. 2149-2157, 2009.
26. L.-F. Lu, E. F. Lind, D. C. Gondek et al., "Mast cells are essential intermediaries in regulatory T-cell tolerance," Nature, vol. 442, no. 7106, pp. 997-1002, 2006.
27. V. Dardalhon, A. Awasthi, H. Kwon et al., "IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3- effector T cells," Nature Immunology, vol. 9, no. 12, pp. 1347-1355, 2008.
28. V. Staudt, E. Bothur, M. Klein et al., "Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells," Immunity, vol. 33, no. 2, pp. 192-202, 2010.
29. M. Veldhoen, C. Uyttenhove, J. van Snick et al., "Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset," Nature Immunology, vol. 9, no. 12, pp. 1341-1346, 2008.
30. C. Wilhelm, J.-E. Turner, J. van Snick, and B. Stockinger, "The many lives of IL-9: a question of survival?" Nature Immunology, vol. 13, no. 7, pp. 637-641, 2012.
31. C. Ran and X. Jian-Hua, "The abnormality and clinical significance of T helper 9 cells and interleukin-9 in patients with rheumatoid arthritis," Chinese Journal of Rheumatology, vol. 32, no. 2, 2012.
32. A. Alunno, M. Manetti, S. Caterbi et al., "Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory Th17 cells and therapeutic implications," Mediators of Inflammation, vol. 2015,Article ID751793, 12pages, 2015.
33. E. Schmitt, M. Klein, and T. Bopp, "Th9 cells, new players in adaptive immunity," Trends in Immunology, vol. 35, no. 2, pp. 61-68, 2014.
34. J. van Snick, A. Goethals, J. C. Renauld et al., "Cloning and characterization of a cDNAfor a newmouse T cell growth factor (P40),"The Journal of ExperimentalMedicine, vol. 169, no. 1, pp. 363-368, 1989.
35. L. Hultner, C. Druez, J. Moeller et al., "Mast cell growthenhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9)," European Journal of Immunology, vol. 20, no. 6, pp. 1413-1416, 1990.
36. A. S. Gounni, B. Gregory, E. Nutku et al., "Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils," Blood, vol. 96, no. 6, pp. 2163-2171, 2000.
37. R. H. Fontaine, O. Cases, V. Lelièvre et al., "IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis," Cell Death and Differentiation, vol. 15, no. 10, pp. 1542-1552, 2008.
38. L. Knoops and J.-C. Renauld, "IL-9 and its receptor: fromsignal transduction to tumorigenesis," Growth Factors, vol. 22, no. 4, pp. 207-215, 2004.
39. G. K. Singhera, R. MacRedmond, and D. R. Dorscheid, "Interleukin-9 and-13 inhibit spontaneous and corticosteroid induced apoptosis of normal airway epithelial cells," Experimental Lung Research, vol. 34, no. 9, pp. 579-598, 2008.
40. J. H. Anolik, "B cell biology: implications for treatment of systemic lupus erythematosus," Lupus, vol. 22, no. 4, pp. 342-349, 2013.
41. J. Yang, Q. Li, X. Yang, and M. Li, "Interleukin-9 is associated with elevated anti-double-stranded DNA antibodies in lupusprone mice," Molecular Medicine, 2015.
42. A. Ramming, H. Schulze-Koops, and A. Skapenko, "Th9 cells. Functionally important or just an epiphenomenon?" Zeitschrift fur Rheumatologie, vol. 71, no. 5, pp. 417-419, 2012.
43. M.H. Kaplan, M. M. Hufford, and M. R. Olson, "The development and in vivo function of T helper 9 cells," Nature Reviews Immunology, vol. 15, no. 5, pp. 295-307, 2015.